Red-Light Therapy for Myopia: Expanding Evidence, Insights, and Experience
Available from: 1/08/2026 (AEST)
Where to publish: https://lms.optometry.org.au/course/view.php?id=1038
Provider: Mivision
Contact: Nikki Byrne, [E] nikki@mivision.com.au, [P] 02 8336 8616
Activity Outline
There’s an expanding evidence base for repeated low-level red-light therapy (RLRL), an emerging non-pharmacological intervention for myopia management. In this article, Dr Sanil Joseph examines the current understanding of the therapy’s proposed mechanisms of action and reviews available clinical safety data. In addition to reviewing the scientific evidence, three Australian practitioners – Vivien Ta, Griffin Ngo, and Philip Cheng – share practical clinical perspectives on integrating RLRL into routine myopia management.
Learning Objectives
- Summarise the current evidence supporting the efficacy and safety of repeated low-level red-light therapy (RLRL) for myopia control
- Describe the proposed mechanisms by which RLRL may influence ocular growth, thereby preventing myopia progression
- Apply practical strategies for integrating RLRL into clinical practice
Max CPD hours awarded: 1.25
Session Information
| Name |
|---|
| Red-Light Therapy for Myopia: Expanding Evidence, Insights, and Experience |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.75 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1.25 |